Seema Singhal, MD

Published: Jul 22, 2019

Tags

Seema Singhal is a Professor of Medicine in hematology and oncology at Northwestern Memorial Hospital. She received her medical degree from Seth G.S. Medical College and has been in practice for more than 20 years. She completed her residency from Bombay University, India and her fellowship from Hadassah University Hospital, Israel.

She specializes in diseases of the blood, spleen and lymph glands, treating such conditions as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia and lymphoma.

Representative Publications:

Phase I Study of the Anti-Fcrh5 Antibody-Drug Conjugate DFRF4539A in Relapsed or Refractory Multiple Myeloma

Daratumumab Monotherapy in Patients With Treatment-Refractory Multiple Myeloma (SIRIUS): An Open-Label, Randomised, Phase 2 Trial

Phase 1/2 Study of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Palbociclib (PD-0332991) With Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Older Adults Newly Diagnosed With Symptomatic Myeloma and Treatment Decision Making

Myeloma is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early During Myelomagenesis

First Name

Seema

Last Name

Singhal

Address

Northwestern Memorial Hospital<br>
676 N Saint Clair Street<br>
Arkes Suite 2330